Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$43.25

-0.41 (-0.94%)

13:49
08/07/18
08/07
13:49
08/07/18
13:49

Piper Jaffray keeps Neutral rating on Ionis with 'glass half full' view

Piper Jaffray analyst Tyler Van Buren said he is keeping his "glass half full" Neutral rating on Ionis after the company reported Q2 results and provided updates on its clinical programs. Waylivra and Tegsedi represent "exciting" opportunities with $1B+ in peak global sales potential by 2025, but Van Buren said attention should be paid to the early launch metrics to gain additional confidence in their ultimate commercial success. The analyst has a $50 price target on Ionis shares.

  • 07

    Aug

  • 30

    Aug

  • 06

    Oct

IONS Ionis Pharmaceuticals
$43.25

-0.41 (-0.94%)

06/20/18
LEHM
06/20/18
NO CHANGE
LEHM
Barclays upgrades PTC to Equal Weight, downgrades Ionis to Underweight
Barclays analyst Gena Wang upgraded PTC Therapeutics (PTCT) to Equal Weight from Underweight while downgrading Ionis Pharmaceuticals (IONS) to Underweight from Equal Weight. The analyst raised her price target on the former to $40 from $26 and lowered her price target on the latter to $45 from $52. Following PTC's new data in spinal muscular atrophy data, the analyst believes its risdiplam has "disruptive potential" to Ionis and Biogen's (BIIB) Spinraza.
07/11/18
PIPR
07/11/18
NO CHANGE
Target $50
PIPR
Neutral
Ionis approval narrower than expected, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren says the European approval of Tegsedi announced this morning Ionis Pharmaceuticals (IONS) and Akcea Therapeutics (AKCA) for the treatment of stage 1 or stage 2 polyneuropoathy in adult patients with hATTR was narrower than he originally expected. The indication is narrower than the broader hATTR patient population, inclusive of both cardiomyopathy and polyneuropathy, but makes sense considering that the pivotal trial primarily enrolled patients with stage 1 and 2 polyneuropathy, Van Buren tells investors in a research note. The analyst adds that while the approval is a positive development and Tegsedi represents the largest near-term pipeline opportunity for Ionis, he wants to observe positive early launch metrics and confirmation of the opportunity before getting more constructive on the shares. He keeps a Neutral rating on Ionis with a $50 price target.
07/23/18
OPCO
07/23/18
NO CHANGE
Target $400
OPCO
Outperform
Oppenheimer anticipating potential volatility ahead for Biogen
Oppenheimer analyst Jay Olson anticipates Biogen (BIIB) volatility driven by Q2 results along with AD presentations at AAIC that include promising BAN2401 data, which was recently top-lined. The analyst expects a focus on ADCOMS component scores and effect sizes for BAN2401. With regards to Q2 results, Olson expects top-line growth of 4% and non-GAAP EPS of $3.95 which is impacted by the Ionis Pharmaceuticals (IONS) deal upfront payment. Additionally, he expects continued strong Spinraza and biosimilar growth. Olson reiterates an Outperform rating and $400 price target on Biogen's shares.
08/07/18
STFL
08/07/18
INITIATION
Target $48
STFL
Hold
Ionis Pharmaceuticals transferred with a Hold at Stifel
Stifel transferred coverage of Ionis Pharmaceuticals (IONS) to analyst Paul Matteis, who set a Hold rating and $48 price target on the shares. The Biogen (BIIB) deal, while validating, limits some of the future upside for Ionis, Matteis tells investors. Also, despite his long-term bullishness on the TTR amyloidisis opportunity, he is below consensus for the first year of the launches for Tegsedi and Waylivra.

TODAY'S FREE FLY STORIES

PPD

Pre-Paid Legal

$0.00

(0.00%)

09:58
11/15/18
11/15
09:58
11/15/18
09:58
Recommendations
Pre-Paid Legal analyst commentary  »

Pre-Paid Legal sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCSF

Bain Capital Specialty Finance

$0.00

(0.00%)

09:57
11/15/18
11/15
09:57
11/15/18
09:57
Recommendations
Bain Capital Specialty Finance analyst commentary  »

Bain Capital Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PCG

PG&E

$21.50

-4.16 (-16.21%)

09:55
11/15/18
11/15
09:55
11/15/18
09:55
Options
PG&E put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$46.30

1.95 (4.40%)

, AVGO

Broadcom

$230.54

4.24 (1.87%)

09:55
11/15/18
11/15
09:55
11/15/18
09:55
Options
Early notable gainers among liquid option names on November 15th »

Notable gainers among…

CSCO

Cisco

$46.30

1.95 (4.40%)

AVGO

Broadcom

$230.54

4.24 (1.87%)

FCX

Freeport McMoRan

$11.80

0.26 (2.25%)

WYNN

Wynn Resorts

$106.40

3.16 (3.06%)

CF

CF Industries

$45.62

0.59 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 26

    Nov

  • 06

    Dec

  • 10

    Jan

ATVI

Activision Blizzard

$51.55

-0.06 (-0.12%)

, EA

Electronic Arts

$85.63

-0.04 (-0.05%)

09:55
11/15/18
11/15
09:55
11/15/18
09:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

ATVI

Activision Blizzard

$51.55

-0.06 (-0.12%)

EA

Electronic Arts

$85.63

-0.04 (-0.05%)

GME

GameStop

$12.98

0.02 (0.15%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$106.89

0.3 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

FBK

FB Financial

$37.72

(0.00%)

, ACBI

Atlantic Capital

$17.05

1.65 (10.71%)

09:55
11/15/18
11/15
09:55
11/15/18
09:55
Conference/Events
Atlantic Capital to hold a conference call »

Management discusses the…

FBK

FB Financial

$37.72

(0.00%)

ACBI

Atlantic Capital

$17.05

1.65 (10.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

LCA

Landcadia

$11.85

0.51 (4.50%)

09:55
11/15/18
11/15
09:55
11/15/18
09:55
Conference/Events
Landcadia to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

09:55
11/15/18
11/15
09:55
11/15/18
09:55
Conference/Events
Senate Banking, Housing & Urban Affairs Committee to hold a hearing »

Federal Reserve Vice…

09:54
11/15/18
11/15
09:54
11/15/18
09:54
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

NCS

NCI Building

$12.35

(0.00%)

09:53
11/15/18
11/15
09:53
11/15/18
09:53
Conference/Events
NCI Building to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

09:50
11/15/18
11/15
09:50
11/15/18
09:50
General news
U.S. business inventories preview: »

U.S. business inventories…

09:49
11/15/18
11/15
09:49
11/15/18
09:49
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

DVMT

Dell Technologies

$107.05

1.3 (1.23%)

, BLK

BlackRock

$397.00

-4.93 (-1.23%)

09:49
11/15/18
11/15
09:49
11/15/18
09:49
Periodicals
BlackRock supportive of revised Dell offer for Class V shares, CNBC says »

CNBC's David Faber…

DVMT

Dell Technologies

$107.05

1.3 (1.23%)

BLK

BlackRock

$397.00

-4.93 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 29

    Jan

BEDU

Bright Scholar

$10.59

-2.18 (-17.07%)

09:47
11/15/18
11/15
09:47
11/15/18
09:47
Hot Stocks
Bright Scholar falls -16.8% »

Bright Scholar is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

UGAZ

VelocityShares 3x Long Natural Gas ETN

$172.78

-79.5 (-31.51%)

09:47
11/15/18
11/15
09:47
11/15/18
09:47
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -32.0% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYB

RYB Education

$9.55

-7.26 (-43.19%)

09:47
11/15/18
11/15
09:47
11/15/18
09:47
Hot Stocks
RYB Education falls -44.4% »

RYB Education is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$5.78

0.43 (8.04%)

09:47
11/15/18
11/15
09:47
11/15/18
09:47
Hot Stocks
Vipshop rises 6.0% »

Vipshop is up 6.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 10

    Dec

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$3.76

0.89 (31.01%)

09:47
11/15/18
11/15
09:47
11/15/18
09:47
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 32.1% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFS

Smart & Final Stores

$5.70

0.74 (14.92%)

09:47
11/15/18
11/15
09:47
11/15/18
09:47
Hot Stocks
Smart & Final Stores rises 15.2% »

Smart & Final Stores…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQNS

Sequans

$1.00

-0.005 (-0.50%)

09:46
11/15/18
11/15
09:46
11/15/18
09:46
Conference/Events
Sequans management to meet with Needham »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

SCOR

comScore

$16.81

(0.00%)

09:45
11/15/18
11/15
09:45
11/15/18
09:45
Conference/Events
comScore management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

09:45
11/15/18
11/15
09:45
11/15/18
09:45
General news
Breaking General news story  »

Federal Reserve Vice…

09:45
11/15/18
11/15
09:45
11/15/18
09:45
General news
Business Inventories to be reported at 10:00 »

September Business…

BCSF

Bain Capital Specialty Finance

$0.00

(0.00%)

09:44
11/15/18
11/15
09:44
11/15/18
09:44
Syndicate
Breaking Syndicate news story on Bain Capital Specialty Finance »

Bain Capital Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

QURE

uniQure

$22.79

(0.00%)

, ONCE

Spark Therapeutics

$40.93

(0.00%)

09:42
11/15/18
11/15
09:42
11/15/18
09:42
Recommendations
uniQure, Spark Therapeutics analyst commentary  »

uniQure's AMT-061…

QURE

uniQure

$22.79

(0.00%)

ONCE

Spark Therapeutics

$40.93

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.